In view of conflicting evidence for a major hepatic role in the synthesis of circulating plasminogen, the precursor of the fibrinolytic enzyme plasmin, we carried out the present study with a sensitive assay in order to measure the accumulation of small quantities of plasminogen in a recycling rat liver perfusion system. We have purified plasminogen from Sprague-Dawley rat plasma and have raised a monospecific antiserum against it in rabbits. Isolated rat liver perfusions were performed with an oxygenated recycling perfusate consisting of a perfluorotributylamine/Pluronic F-68 emulsion (Fluosol 43) These data indicate that theliver is a major site of plasminogen production.
Plasminogen, a protein of Mr t85,000, is present in all mammalian plasmas and is a precursor of the proteolytic (fibrinolytic) enzyme plasmin. Activation of the precursor initiates the process of dissolution of intravascular fibrin deposits (1) .
The site of synthesis of plasminogen has not been established with certainty, and several organs and tissues have been proposed as possible sources. Earlier immunofluorescence studies demonstrated plasminogen in eosinophilic granulocytes and led to the suggestion that the protein was produced in developing eosinophils of the bone marrow (2) . Although the kidney has been implicated as a site of synthesis (3), plasma concentrations and de novo biosynthesis of plasminogen are maintained in anephric rats (4) . In contrast, the decreased titer of plasma plasminogen in patients with advanced hepatic cirrhosis (5) suggests that the liver may be a major site of production in man. This conclusion is supported by the recent observation that, after hepatic homotransplantation in man, the plasminogen phenotype of the host converted to that of the donor (6) .
Although a previous study failed to identify release of plasminogen by the isolated perfused rat liver (7), the search for small quantities of the protein in the perfusate may have been hindered by the lack of a sensitive assay technique at that time.
In the present paper we describe a specific and sensitive radioimmunoassay for rat plasminogen that is capable of detecting increasing titers of plasminogen in the plasma-free perfluorochemical perfusing the isolated rat liver. Inhibition of the increase in titer and of incorporation of a labeled leucine by cycloheximide confirmed that the liver is a site of de novo biosynthesis of plasminogen. Furthermore, the rate of release of plasminogen is compatible with the conclusion that the liver is the predominant site of synthesis in vivo. The findings of our study have been presented in abstract form (8) . Since this work was completed, evidence has appeared for the capacity of rat hepatocytes in culture to synthesize plasminogen during a period of 48 hr (9) .
MATERIALS AND METHODS Materials. Rat plasminogen was isolated from pooled, citrated plasma of Sprague-Dawley rats (Pel-Freez) by lysineSepharose affinity chromatography (10) and Sephadex G-150 column chromatography. The purified preparation showed a sharp single band (Mr, 85,000) on NaDodSO4/polyacrylamide gel electrophoresis before and after reduction with 2-mercaptoethanol (11) . After activation by human urokinase (Abbokinase, Abbott), it had a specific activity of 20.5 CTA units/mg of protein (Committee on Thrombolytic Agents) in a caseinolytic assay (12) and it digested 16.4 nmol of S-2251 (Kabi Diagnostics, Stockholm, Sweden) per min per ,ug in an amidolytic assay (13) .
Lysine-Sepharose and rat plasminogen-Sepharose were prepared by covalently coupling lysine and purified rat plasminogen, respectively, to CNBr-activated Sepharose 4B (Pharmacia) according to the instructions of the manufacturers.
Antiserum to purified rat plasminogen was raised in New Zealand albino rabbits, and a crude immunoglobulin fraction was isolated (14) . Upon Ouchterlony immunodiffusion against rat plasma and purified rat plasminogen, this antiserum formed a single precipitin line of complete identity, but there was no reaction with rat plasma that had been filtered through a lysine-Sepharose column. The crude immunoglobulin fraction of normal rabbit serum was used as a control in experiments involving antiserum against plasminogen. In some experiments, antiplasminogen antibodies purified by affinity chromatography were used. A crude immunoglobulin fraction of antiplasminogen serum (11.0 ml) was applied to a rat plasminogen-Sepharose column (packed volume, 8 .0 ml) equilibrated with 0.5 M NaCl in barbital/saline buffer at room temperature. Antibodies bound to the column were eluted with 4 M guanidine-HCl and dialyzed exhaustively against barbital/saline buffer.
Bovine serum albumin (Pentex, crystallized) and Trasylol Abbreviation: EACA, c-aminocaproic acid.
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(aprotinin) were purchased from Miles and Sigma, respectively. Barbital/saline buffer was 0.025 M sodium barbital in 0.'125 M sodium chloride at pH 7.4. All other chemicals used were reagent grade.
Radioimmunoassay for Rat Plasminogen. A specific and sensitive radioimmunoassay was developed with purified rat plasminogen and its antiserum, as described (15) . The assay mixture consisted of 0.5 ml of bovine serum albumin [1 mg/ml in barbital/saline buffer containing 20 units of aprotinin (Trasylol) per ml], 0.01 ml of 125I-labeled rat plasminogen, 0.1 ml of test sample diluted appropriately in barbital/saline buffer, and 0.1 ml of 1:2000 dilution of anti-rat plasminogen antiserum in 10 X 75 mm polystyrene tubes. After incubation at 4VC for 3 days, 0.1 ml of 1:50 dilution of normal rabbit serum and 0.1 ml of 1:16 dilution of goat anti-rabbit IgG antiserum (Antibodies, Inc.) were added to the mixture. Normal rabbit serum was used as a carrier to increase the volume of the precipitates formed. After incubation overnight at 40C, the tubes were centrifuged at 1800 X g for 10 min at 20C, the supernatant fluids were aspirated, and the radioactivity of the precipitates was determined. The values obtained were expressed as percentage of bound (immunoprecipitable) radioactivity relative to that of total radioactivity initially added to the tube.
Maximal binding, determined from a mixture containing all reagents except the sample, was usually between 85% and 90%. Nonspecific binding (precipitation) of 125I-labeled rat plasminogen, as determined by substituting normal rabbit serum for anti-rat plasminogen antiserum, was consistently less than 12%. Duplicate determinations were performed for each test sample, and serial dilutions of purified rat plasminogen or normal rat pooled plasma were included in each experiment. A standard curve was obtained by plotting the percentage of bound radioactivity against the logarithm of the concentration of purified plasminogen or normal rat pooled plasma (Fig. 1) . The displacement curves obtained with normal rat plasma and purified plasminogen were similar. In contrast, rat plasma depleted of plasminogen by use of a lysine-Sepharose column did not compete for binding of 125I-labeled plasminogen to the antiserum at any concentration. These data demonstrate the Rat plasminogen, Mug/ml specificity of this assay for rat plasminogen. The assay is sensitive to 0.15 Mug of plasminogen per ml or 0.06% of the plasminogen present in normal rat plasma. The concentration of plasminogen in rat plasma was estimated to be approximately 240 Mg/ml.
Perfusion. Rat livers from Sprague-Dawley rats (250-400 g) were perfused at 370C through the portal vein with a recycling perfusate (80 ml) of perfluorotributylamine/pluronic F-68 emulsion (Fluosol 43; Green Cross Corporation, Osaka, Japan), free of plasma proteins and erythrocytes, heparinized with 3000 units of heparin, and maintained in an atmosphere of 95% 02/5% CO2 by means of a membrane oxygenator. A similar nonhemoglobin oxygenation system has been shown to maintain viability of the liver for at least 5 hr (16) . Synthesis of albumin and transferrin and secretion of bile were similar to those previously found with a recycling erythrocyte/plasma perfusate (17) .
Samples of perfusate (3-5 ml) were withdrawn at intervals and centrifuged at 12,000 X g for 30 min to remove the suspended perfluorochemicals. The clear supernatant, to which aprotinin was added (10 units/ml), was assayed for plasminogen by radioimmunoassay. Preliminary experiments showed that all the rat plasminogen present in the suspension was recovered in the supernatant and that the presence of supernatant or cycloheximide in the assay mixture did not interfere with the radioimmunoassay. The rate of plasminogen production and release, expressed as ug/hr per 100 g of body weight, was calculated from the cumulative pool of plasminogen which was obtained by multiplying the perfusate concentration by the supernatant volume after allowing for sampling. In some experiments, 50 MCi (1 Ci = 3.7 X 1010 becquerels) of 14C-labeled
]leucine (342 mCi/mmol); New England Nuclear] was added to the reservoir at the start of the perfusion, and incorporation was determined during a 2-hr period. In other experiments, both the release of immunoassayable plasminogen and the incorporation of ['4C]leucine into plasminogen were studied after addition of cycloheximide (18 uM) part way through the perfusion. This is a concentration that has been shown to inhibit production of several plasma proteins by the isolated perfused rat liver (18 ['4C ]leucine was exhaustively dialyzed against 1 mM nonradioactive leucine in barbital/saline buffer. Dialyzed perfusate was then filtered through a 2-ml column of lysine-Sepharose. The column was washed with 100 ml of barbital/saline buffer containing 20 units of aprotinin per ml and was then eluted with 0.2 M e-aminocaproic acid (EACA). Fractions (1 ml) were collected, dialyzed against barbital/saline buffer, and assayed for 14C radioactivity and plasminogen concentration. The fractions rich in 14C were pooled and divided into two aliquots. One aliquot was incubated with 0.1 ml of rabbit anti-rat plasminogen IgG (1.7 mg/ml) for 1 hr at 370C and then overnight at 4°C. The other aliquot was incubated with normal rabbit IgG (1.7 mg/ml) in the same way. Onetenth milliliter of goat anti-rabbit IgG antiserum was then added to each mixture and the tubes were incubated overnight at 4°C. The resulting immunoprecipitates were centrifuged and washed three times with ice-cold barbital/saline buffer.
The concentrations of anti-rat plasminogen antiserum and goat anti-rabbit IgG antiserum were selected to precipitate all the plasminogen present in the EACA eluates. To achieve this selection, anti-rat plasminogen antibodies isolated by affinity chromatography were used in some experiments. The washed immunoprecipitates were dissolved in 0.1 ml of Hyamine hy-droxide (New England Nuclear) and assayed in a NuclearChicago (Nuclear-Chicago) liquid scintillation spectrometer after the addition of Aquasol scintillator (New England Nuclear). In some experiments, the washed immunoprecipitates were dissolved in 0.1 ml of 5% NaDodSO4/8 M urea/5% 2-mercaptoethanol, boiled for 5 min, and analyzed by NaDodSO4/polyacrylamide gel electrophoresis. The gels were cut into 2-mm segments and dissolved in 1% periodic acid (19) ; after the addition of scintillator, 14C was measured in a liquid scintillation spectrometer.
RESULTS
Appearance of Plasminogen in the Perfusate. The amount of plasminogen present in the perfusate increased progressively during 2 hr of perfusion (Fig. 2) (Fig. 2) . At 120 min the difference between the plasminogen titers in the control and cycloheximide-treated groups was statistically significant (P < 0.05). These data suggest that cycloheximide blocked the net appearance of plasminogen in the perfusate by inhibition of de novo synthesis of the protein.
Incorporation of [14C]Leucine into the EACA Eluate of
the Lysine-Sepharose Columns. To determine whether plasminogen present in the perfusate was newly synthesized by the liver, the liver was perfused in the presence of [14C]leucine. We utilized a unique property of plasminogen: plasminogen binds to lysine-Sepharose and is eluted by EACA (10) . When the perfusate at 120 min was filtered through a column of lysineSepharose and the material adsorbed to the column was eluted with 0.2 M EACA, the eluates contained both 14C radioactivity and plasminogen (Fig. 3) . When the specific immunoprecipitates were examined by NaDodSO4/polyacrylamide gel electrophoresis, peak radioactivity was present at Mr 82,000 (Fig. 4) , similar to that of rat plasminogen (Mr # 85,000). No radioactive bands were detected in the control immunoprecipitates with normal rabbit IgG.
DISCUSSION
The present study provides evidence for the synthesis and release of plasminogen by the rat liver perfused in isolation. The validity of the results depends on the specificity both of the radioimmunoassay for rat plasminogen and of the technique for identification of radioactive labeling of newly synthesized plasminogen.
The rat plasminogen preparation used for immunizing rabbits was homogeneous upon NaDodSO4/polyacrylamide gel electrophoresis. When activated by urokinase, it showed specific enzymatic activities. The antiserum raised against this preparation was shown to contain antibodies specific for rat plasminogen. In the radioimmunoassay the slopes of the dis- 10 Atg/100 g body weight may have been present in the liver at the start of perfusion. Although it is difficult to be certain about the absolute rate of synthesis, it is apparent that the liver may largely account for the synthetic component of the observed rate of turnover in vtivo (21) . Because the circulating plasma concentration of plasminogen is kept constantwithin a relatively narrow range, it is attractive to postulate that hepatic synthesis may be sensitive to factors that lead to increased degradation of plasminogen. The liver perfusion method with perfluorochemicals may provide a convenient and valid system for identification of some of the homeostatic mechanisms in plasminogen metabolism.
